Notice: This CMS-approved document has been submitted - Philips ...

Notice: This CMS-approved document has been submitted - Philips ... Notice: This CMS-approved document has been submitted - Philips ...

healthcare.philips.com
from healthcare.philips.com More from this publisher
19.02.2013 Views

CMS-1403-FC TABLE 51: Impact of CY 2009 Changes in Payments to Hospital-Based and Independent ESRD Facilities [Percent change in composite rate payments to ESRD facilities (both program and beneficiaries)] 1058 1 2 3 4 5 6 7 Number Of facilities Number of Dialysis Treatments (in millions) Effect of Changes in Wage Index 1 / Effect of of the MIPPA provisions only 2 / Overall effect without drug add-on 3 / By Region New England 154 1.2 1.2 0.5 1.8 1.5 Middle Atlantic 566 4.6 0.1 0.2 0.3 0.0 East North Central 768 5.8 -1.0 0.6 -0.4 -0.7 West North Central 372 2.0 0.0 0.3 0.3 0.0 South Atlantic 1104 8.3 -0.1 0.8 0.8 0.5 East South Central 379 2.7 -1.0 0.9 0.0 -0.3 West South Central 667 5.2 -0.5 0.9 0.3 0.1 Mountain 259 1.6 0.0 0.7 0.7 0.5 Pacific 555 4.6 2.2 0.8 3.0 2.7 Puerto Rico & Virgin Islands 34 0.4 -4.6 0.8 -3.8 -4.1 1/This column shows the overall effect of wage index changes on ESRD providers. Composite rate payments computed using the current wage index are compared to composite rate payments using the CY 2009 wage index changes. This column does not include the drug add-on to the composite rate. 2/This column shows the effect of the MIPPA provisions which include a 1 percent increase to composite rate and elimination of separate composite rate for hospital-based ESRD providers. These provisions are effective January 1, 2009. This column does not include the drug add-on to the composite rate. 3/This column shows the percent change between CY 2009 and CY 2008 composite rate payments to ESRD facilities. This column does not include the drug add-on to the composite rate. Overall effect including drug add-on 4 / All Providers 4,858 36.4 0.0 0.7 0.7 0.4 Independent 4,303 32.8 0.0 1.0 1.0 0.7 Hospital Based 555 3.7 0.2 -2.1 -1.9 -2.1 By Facility Size Less than 5000 treatments 1,732 5.0 -0.1 0.6 0.5 0.2 5000 to 9999 treatments 1,915 13.9 0.0 0.8 0.8 0.5 Greater than 9999 treatments 1,211 17.6 0.0 0.6 0.6 0.4 Type of Ownership Profit 3,932 29.8 0.0 1.0 0.9 0.7 Nonprofit 926 6.6 0.2 -0.7 -0.5 -0.7 By Geographic Location Rural 1,320 7.6 -0.5 0.6 0.1 -0.1 Urban 3,538 28.8 0.1 0.7 0.8 0.5

CMS-1403-FC 1059 4/This column shows the percent change between CY 2009 and CY 2008 composite rate payments to ESRD facilities. The CY 2009 payments include the CY 2009 wage adjusted composite rate, and the 15.2 percent drug add-on times treatments The CY 2008 payments to ESRD facilities includes the CY 2008 wage adjusted composite rate and the 15.5 percent drug add-on times treatments. G. IDTF Issues We believe that the provisions regarding IDTFs as discussed in Section II.I. of this final rule with comment period will have minimal budgetary impact. We believe that the IDTF enrollment provisions contained in this rule are necessary and will help ensure that beneficiaries receive quality care by making certain that those entities providing mobile diagnostic testing services meet established performance standards and are enrolled in the Medicare program as IDTFs. We maintain that that most of these mobile units providing diagnostic testing services are already enrolled as IDTFs as required in §410.33(g), however we have no way of determining how many of these units are providing mobile diagnostic testing services, yet are not enrolled. We do not believe that beneficiary access to IDTF services will be affected by these requiring mobile units providing diagnostic testing services to enroll in the Medicare program. H. Physician and Nonphysician Practitioner Enrollment Issues

<strong>CMS</strong>-1403-FC<br />

TABLE 51: Impact of CY 2009 Changes in Payments to<br />

Hospital-Based and Independent ESRD Facilities<br />

[Percent change in composite rate payments to ESRD facilities (both<br />

program and beneficiaries)]<br />

1058<br />

1 2 3 4 5 6 7<br />

Number<br />

Of<br />

facilities<br />

Number of<br />

Dialysis<br />

Treatments<br />

(in<br />

millions)<br />

Effect of<br />

Changes<br />

in Wage<br />

Index 1 /<br />

Effect of<br />

of the<br />

MIPPA<br />

provisions<br />

only 2 /<br />

Overall<br />

effect<br />

without<br />

drug<br />

add-on 3 /<br />

By Region<br />

New England 154 1.2 1.2 0.5 1.8 1.5<br />

Middle Atlantic 566 4.6 0.1 0.2 0.3 0.0<br />

East North Central 768 5.8 -1.0 0.6 -0.4 -0.7<br />

West North Central 372 2.0 0.0 0.3 0.3 0.0<br />

South Atlantic 1104 8.3 -0.1 0.8 0.8 0.5<br />

East South Central 379 2.7 -1.0 0.9 0.0 -0.3<br />

West South Central 667 5.2 -0.5 0.9 0.3 0.1<br />

Mountain 259 1.6 0.0 0.7 0.7 0.5<br />

Pacific 555 4.6 2.2 0.8 3.0 2.7<br />

Puerto Rico & Virgin Islands 34 0.4 -4.6 0.8 -3.8 -4.1<br />

1/<strong>This</strong> column shows the overall effect of wage index changes on ESRD providers. Composite rate<br />

payments computed using the current wage index are compared to composite rate payments using the<br />

CY 2009 wage index changes. <strong>This</strong> column does not include the drug add-on to the composite rate.<br />

2/<strong>This</strong> column shows the effect of the MIPPA provisions which include a 1 percent increase to composite<br />

rate and elimination of separate composite rate for hospital-based ESRD providers. These provisions are<br />

effective January 1, 2009. <strong>This</strong> column does not include the drug add-on to the composite rate.<br />

3/<strong>This</strong> column shows the percent change between CY 2009 and CY 2008 composite rate payments to<br />

ESRD facilities. <strong>This</strong> column does not include the drug add-on to the composite rate.<br />

Overall<br />

effect<br />

including<br />

drug<br />

add-on 4 /<br />

All Providers 4,858 36.4 0.0 0.7 0.7 0.4<br />

Independent 4,303 32.8 0.0 1.0 1.0 0.7<br />

Hospital Based 555 3.7 0.2 -2.1 -1.9 -2.1<br />

By Facility Size<br />

Less than 5000 treatments 1,732 5.0 -0.1 0.6 0.5 0.2<br />

5000 to 9999 treatments 1,915 13.9 0.0 0.8 0.8 0.5<br />

Greater than 9999 treatments 1,211 17.6 0.0 0.6 0.6 0.4<br />

Type of Ownership<br />

Profit 3,932 29.8 0.0 1.0 0.9 0.7<br />

Nonprofit 926 6.6 0.2 -0.7 -0.5 -0.7<br />

By Geographic Location<br />

Rural 1,320 7.6 -0.5 0.6 0.1 -0.1<br />

Urban 3,538 28.8 0.1 0.7 0.8 0.5

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!